207 related articles for article (PubMed ID: 36702538)
1. Ocrelizumab Treatment Modulates B-Cell Regulating Factors in Multiple Sclerosis.
Ho S; Oswald E; Wong HK; Vural A; Yilmaz V; Tüzün E; Türkoğlu R; Straub T; Meinl I; Thaler F; Kümpfel T; Meinl E; Mader S
Neurol Neuroimmunol Neuroinflamm; 2023 Mar; 10(2):. PubMed ID: 36702538
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal Fluid Biomarkers in Relation to MRZ Reaction Status in Primary Progressive Multiple Sclerosis.
Robinson T; Abdelhak A; Bose T; Meinl E; Otto M; Zettl UK; Dersch R; Tumani H; Rauer S; Huss A
Cells; 2020 Nov; 9(12):. PubMed ID: 33255854
[TBL] [Abstract][Full Text] [Related]
3. Features of Isoforms of Human Soluble TACI.
Fichtner ML; Rübsamen H; Smolle M; Schaller J; Feederle R; Bültmann A; Kümpfel T; Schneider P; Thaler FS; Meinl E
J Immunol; 2023 Jul; 211(2):199-208. PubMed ID: 37272840
[TBL] [Abstract][Full Text] [Related]
4. The immunoregulator soluble TACI is released by ADAM10 and reflects B cell activation in autoimmunity.
Hoffmann FS; Kuhn PH; Laurent SA; Hauck SM; Berer K; Wendlinger SA; Krumbholz M; Khademi M; Olsson T; Dreyling M; Pfister HW; Alexander T; Hiepe F; Kümpfel T; Crawford HC; Wekerle H; Hohlfeld R; Lichtenthaler SF; Meinl E
J Immunol; 2015 Jan; 194(2):542-52. PubMed ID: 25505277
[TBL] [Abstract][Full Text] [Related]
5. Soluble TACI and soluble BCMA as biomarkers in primary central nervous system lymphoma.
Thaler FS; Laurent SA; Huber M; Mulazzani M; Dreyling M; Ködel U; Kümpfel T; Straube A; Meinl E; von Baumgarten L
Neuro Oncol; 2017 Nov; 19(12):1618-1627. PubMed ID: 28521029
[TBL] [Abstract][Full Text] [Related]
6. The role of the BAFF/APRIL system in the T cell-independent specific response to blood stage Plasmodium falciparum hemozoin.
Dechkajorn W; Benjathummarak S; Kumsiri R; Maneerat Y
Cytokine; 2018 Nov; 111():445-453. PubMed ID: 29884307
[TBL] [Abstract][Full Text] [Related]
7. Analysis of serum B cell-activating factor from the tumor necrosis factor family (BAFF) and its soluble receptors in systemic lupus erythematosus.
Vincent FB; Kandane-Rathnayake R; Koelmeyer R; Hoi AY; Harris J; Mackay F; Morand EF
Clin Transl Immunology; 2019; 8(4):e01047. PubMed ID: 31024730
[TBL] [Abstract][Full Text] [Related]
8. Endogenous soluble receptors sBCMA and sTACI: biomarker, immunoregulator and hurdle for therapy in multiple myeloma.
Meinl E; Krumbholz M
Curr Opin Immunol; 2021 Aug; 71():117-123. PubMed ID: 34330018
[TBL] [Abstract][Full Text] [Related]
9. The role of TNF-α superfamily members in immunopathogenesis of sepsis.
Lendak DF; Mihajlović DM; Novakov-Mikić AS; Mitić IM; Boban JM; Brkić SV
Cytokine; 2018 Nov; 111():125-130. PubMed ID: 30142533
[TBL] [Abstract][Full Text] [Related]
10. BAFF-R and TACI expression on CD3+ T cells: Interplay among BAFF, APRIL and T helper cytokines profile in systemic lupus erythematosus.
Salazar-Camarena DC; Ortíz-Lazareno P; Marín-Rosales M; Cruz A; Muñoz-Valle F; Tapia-Llanos R; Orozco-Barocio G; Machado-Contreras R; Palafox-Sánchez CA
Cytokine; 2019 Feb; 114():115-127. PubMed ID: 30467093
[TBL] [Abstract][Full Text] [Related]
11. Lymphoma B cells evade apoptosis through the TNF family members BAFF/BLyS and APRIL.
He B; Chadburn A; Jou E; Schattner EJ; Knowles DM; Cerutti A
J Immunol; 2004 Mar; 172(5):3268-79. PubMed ID: 14978135
[TBL] [Abstract][Full Text] [Related]
12. APRIL and sTACI could be predictors of multiorgan dysfunction syndrome in sepsis.
Lendak DF; Mihajlović DM; Novakov-Mikić AS; Boban JM; Ubavić M; Brkić SV
Virulence; 2018 Dec; 9(1):946-953. PubMed ID: 29781374
[TBL] [Abstract][Full Text] [Related]
13. Fingolimod induces BAFF and expands circulating transitional B cells without activating memory B cells and plasma cells in multiple sclerosis.
Miyazaki Y; Niino M; Takahashi E; Suzuki M; Mizuno M; Hisahara S; Fukazawa T; Amino I; Nakano F; Nakamura M; Akimoto S; Minami N; Fujiki N; Doi S; Shimohama S; Terayama Y; Kikuchi S
Clin Immunol; 2018 Feb; 187():95-101. PubMed ID: 29079163
[TBL] [Abstract][Full Text] [Related]
14. Treatment-Induced BAFF Expression and B Cell Biology in Multiple Sclerosis.
Smets I; Prezzemolo T; Imbrechts M; Mallants K; Mitera T; Humblet-Baron S; Dubois B; Matthys P; Liston A; Goris A
Front Immunol; 2021; 12():676619. PubMed ID: 34122439
[TBL] [Abstract][Full Text] [Related]
15. Kinetics of free and ligand-bound atacicept in human serum.
Eslami M; Willen D; Papasouliotis O; Schuepbach-Mallpell S; Willen L; Donzé O; Yalkinoglu Ö; Schneider P
Front Immunol; 2022; 13():1035556. PubMed ID: 36532058
[TBL] [Abstract][Full Text] [Related]
16. APRIL and BAFF promote increased viability of replicating human B2 cells via mechanism involving cyclooxygenase 2.
Mongini PK; Inman JK; Han H; Fattah RJ; Abramson SB; Attur M
J Immunol; 2006 Jun; 176(11):6736-51. PubMed ID: 16709833
[TBL] [Abstract][Full Text] [Related]
17. B cells in MS and NMO: pathogenesis and therapy.
Krumbholz M; Meinl E
Semin Immunopathol; 2014 May; 36(3):339-50. PubMed ID: 24832354
[TBL] [Abstract][Full Text] [Related]
18. B Cell-Activating Factor Neutralization Aggravates Atherosclerosis.
Tsiantoulas D; Sage AP; Göderle L; Ozsvar-Kozma M; Murphy D; Porsch F; Pasterkamp G; Menche J; Schneider P; Mallat Z; Binder CJ
Circulation; 2018 Nov; 138(20):2263-2273. PubMed ID: 29858401
[TBL] [Abstract][Full Text] [Related]
19. Expressions of BAFF/BAFF receptors and their correlation with disease activity in Chinese SLE patients.
Zhao LD; Li Y; Smith MF; Wang JS; Zhang W; Tang FL; Tian XP; Wang HY; Zhang FC; Ba DN; He W; Zhang X
Lupus; 2010 Nov; 19(13):1534-49. PubMed ID: 20974656
[TBL] [Abstract][Full Text] [Related]
20. BAFF and APRIL protect myeloma cells from apoptosis induced by interleukin 6 deprivation and dexamethasone.
Moreaux J; Legouffe E; Jourdan E; Quittet P; Rème T; Lugagne C; Moine P; Rossi JF; Klein B; Tarte K
Blood; 2004 Apr; 103(8):3148-57. PubMed ID: 15070697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
